Diagnosis of early stage ovarian cancer by 1H NMR metabonomics of serum explored by use of a microflow NMR probe

Journal of Proteome Research

Volumn 10, Issue 4, 2011, Pages 1765-1771

  Garcia, Erwin ^a   Andrews, Chris ^a   Hua, Jia ^a   Kim, Hyung L ^b,c   Sukumaran, Dinesh K ^a   Szyperski, Thomas ^a   Odunsi, Kunle ^b  

^a UNIVERSITY AT BUFFALO   (United States)

^b ROSWELL PARK CANCER INSTITUTE   (United States)

^c CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

cancer type specificity; early stage detection; metabonomics; microflow probe; NMR; ovarian cancer; predictive statistical model; principal component analysis

Indexed keywords

ARTICLE; CANCER STAGING; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; METABOLOMICS; OVARY CANCER; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SENSITIVITY AND SPECIFICITY; SERODIAGNOSIS; STATISTICAL MODEL; VALIDATION STUDY;

AREA UNDER CURVE; FEMALE; HUMANS; METABOLOMICS; NEOPLASM STAGING; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; OVARIAN NEOPLASMS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 79953708853     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr101050d     Document Type: Article

References (30)

1. Armstrong, D. K.; Bundy, B.; Wenzel, L.; Huang, H. Q.; Baergen, R.; Lele, S.; Copeland, L. J.; Walker, J. L.; Burger, R. A. Intraperitoneal cisplatin and paclitaxel in ovarian cancer N. Engl. J. Med. 2006, 354, 34-43 (Pubitemid 43048949)
2. Bookman, M. A.; Brady, M. F.; McGuire, W. P.; Harper, P. G.; Alberts, D. S.; Friedlander, M.; Colombo, N.; Fowler, J. M.; Argenta, P. A.; De Geest, K.; Mutch, D. G.; Burger, R. A.; Swart, A. M.; Trimble, E. L.; Accario-Winslow, C.; Roth, L. M. Evaluation of new platinum-based treatment regimens in advanced-stage ovarian cancer: a phase III trial of the Gynecologic Cancer Intergroup J. Clin. Oncol. 2009, 27, 1419-1425
3. Greenlee, R. T.; Hill-Harmon, M. B.; Murray, T.; Thun, M. Cancer statistics, 2001. CA Cancer J. Clin. 2001, 51, 15 - 36.
4. Young, R. C.; Walton, L. A.; Ellenberg, S. S.; Homesley, H. D.; Wilbanks, G. D.; Decker, D. G.; Miller, A.; Park, R.; Major, F., Jr. Adjuvant therapy in stage I and stage II epithelial ovarian cancer. Results of two prospective randomized trials N. Engl. J. Med. 1990, 322, 1021-1027 (Pubitemid 20146659)
5. Jacobs, I. Overview-progress in screening for ovarian cancer. In Ovarian Cancer 5; Sharp, F.; Blackett, A.; Berek, J.; Bast, R., Eds.; Isis Medical Media Ltd: Oxford, 1998; pp 173 - 185.
6. Buys, S. S.; Partridge, E.; Greene, M. H.; Prorok, P. C.; Reding, D.; Riley, T. L.; Hartge, P.; Fagerstrom, R. M.; Ragard, L. R.; Chia, D.; Izmirlian, G.; Fouad, M.; Johnson, C. C.; Gohagan, J. K. Ovarian cancer screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening trial: findings from the initial screen of a randomized trial Am. J. Obstet. Gynecol. 2005, 193, 1630-1639 (Pubitemid 41540458)
7. Partridge, E.; Kreimer, A. R.; Greenlee, R. T.; Williams, C.; Xu, J. L.; Church, T. R.; Kessel, B.; Johnson, C. C.; Weissfeld, J. L.; Isaacs, C.; Andriole, G. L.; Ogden, S.; Ragard, L. R.; Buys, S. S. Results from four rounds of ovarian cancer screening in a randomized trial Obstet. Gynecol. 2009, 113, 775-782
8. Lindon, J. C.; Nicholson, J. K.; Holmes, E. The Handbook of Metabonomics and Metabolomics; Elsevier: Amsterdam, 2007.
9. Nicholson, J. K.; Lindon, J. C.; Holmes, E. Metabonomics: understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data Xenobiotica 1999, 29, 1181-1189
10. Lindon, J. C.; Nicholson, J. K.; Everett, J. R. NMR spectroscopy of biofluids Annu. Rep. NMR Spectrosc. 1999, 38, 1-88
11. Lindon, J. C.; Nicholson, J. K.; Holmes, E.; Everett, J. R. Metabonomics: metabolic processes studied by NMR spectroscopy of biofluids Concepts Magn. Reson. 2000, 12, 289-320
12. Nicholson, J. K.; Connelly, J.; Lindon, J. C.; Holmes, E. Metabonomics: a platform for studying drug toxicity and gene function Nat. Rev. Drug Discovery 2002, 1, 153-161 (Pubitemid 41646523)
13. Ambrosone, C. B.; Nesline, M. K.; Davis, W. Establishing a cancer center data bank and biorepository for multidisciplinary research Cancer Epidemiol., Biomarkers Prev. 2006, 15, 1575-1577 (Pubitemid 44497088)
14. Sukumaran, D.; Garcia, E.; Hua, J.; Tabaczynski, W.; Odunsi, K.; Andrews, C.; Szyperski, T. Standard operating procedure for metabonomics studies of blood serum and plasma samples using a 1H-NMR micro-flow probe Magn. Reson. Chem. 2009, 47 (Suppl. 1) S81-885
15. Beckonert, O.; Keun, H. C.; Ebbels, T. M.; Bundy, J.; Holmes, E.; Lindon, J. C.; Nicholson, J. K. Metabolic profiling, metabolomic and metabonomic procedures for NMR spectroscopy of urine, plasma, serum and tissue extracts Nat. Protoc. 2007, 2, 2692-2703
16. 13C NMR spectroscopy of human blood plasma Anal. Chem. 1995, 67, 793-811
17. Lindon, J. C.; Nicholson, J. K.; Everette, J. R. NMR spectroscopy of biofluids Annu. Rep. NMR Spectrosc. 1999, 38, 1-88
18. 1H NMR data sets Anal. Chem. 2005, 77, 1282-1289 (Pubitemid 40327865)
19. Steyerberg, E. W. Clinical Prediction Models: A Practical Approach to Development, Validation, and Updating; Springer: New York, 2009.
20. 1H NMR-based metabonomics in the study of metabolic profiling of human hepatocellular carcinoma and liver cirrhosis Cancer Sci. 2009, 100, 782-785
21. Tiziani, S.; Lopes, V.; Günther, U. L. Early stage diagnosis of oral cancer using 1H NMR-based metabolomics Neoplasia 2009, 11, 269-276
22. Ludwig, C.; Ward, D. G.; Martin, A.; Viant, M. R.; Ismail, T.; Johnson, P. J.; Wakelam, M. J. O.; Günther, U. L. Fast targeted multidimensional NMR metabolomics of colorectal cancer Magn. Reson. Chem. 2009, 47, S68-S73
23. 1H NMR metabonomics analysis in renal cell carcinoma: a possible diagnostic tool J. Proteome Res. 2010, 9, 4038-4044
24. Menon, U.; Gentry-Maharaj, A.; Hallett, R.; Ryan, A.; Burnell, M.; Sharma, A.; Lewis, S.; Davies, S.; Philpott, S.; Lopes, A.; Godfrey, K.; Oram, D.; Herod, J.; Williamson, K.; Seif, M. W.; Scott, I.; Mould, T.; Woolas, R.; Murdoch, J.; Dobbs, S.; Amso, N. N.; Leeson, S.; Cruickshank, D.; Mcguire, A.; Campbell, S.; Fallowfield, L.; Singh, N.; Dawnay, A.; Skates, S. J.; Parmar, M.; Jacobs, I. Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS) Lancet Oncol. 2009, 10, 327-340
25. Kulasingam, V.; Pavlou, M. P.; Diamandis, E. P. Integrating high-throughput technologies in the quest for effective biomarkers for ovarian cancer Nat. Rev. Cancer 2010, 10, 371-378
26. Visintin, I.; Feng, Z.; Longton, G.; Ward, D. C.; Alvero, A. B.; Lai, Y.; Tenthorey, J.; Leiser, A.; Flores-Saaib, R.; Yu, H.; Azori, M.; Rutherford, T.; Schwartz, P. E.; Mor, G. Diagnostic markers for early detection of ovarian cancer Clin. Cancer Res. 2008, 14, 1065-1072 (Pubitemid 351302552)
27. Odunsi, K.; Wollman, R. M.; Ambrosone, C. B.; Hutson, A.; McCann, S. E.; Tammela, J.; Geisler, J. P.; Miller, G.; Sellers, T.; Cliby, W.; Qian, F.; Keitz, B.; Intengan, M.; Lele, S.; Alderfer, J. L. Detection of epithelial ovarian cancer using 1H-NMR-based metabonomics Int. J. Cancer 2005, 113, 782-788 (Pubitemid 40101260)
28. Antoniou, A.; Pharoah, P. D.; Narod, S.; Risch, H. A.; Eyfjord, J. E.; Hopper, J. L.; Loman, N.; Olsson, H.; Johannsson, O.; Borg, A.; Pasini, B.; Radice, P.; Manoukian, S.; Eccles, D. M.; Tang, N.; Olah, E.; Anton-Culver, H.; Warner, E.; Lubinski, J.; Gronwald, J.; Gorski, B.; Tulinius, H.; Thorlacius, S.; Eerola, H.; Nevanlinna, H.; Syrjäkoski, K.; Kallioniemi, O. P.; Thompson, D.; Evans, C.; Peto, J.; Lalloo, F.; Evans, D. G.; Easton, D. F. Average risks of breast and ovarian cancer associated with BRCA1 and BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies Am. J. Hum. Genet. 2003, 72, 1117-1130 (Pubitemid 36530000)
29. Anderson, G. L.; McIntosh, M.; Wu, L.; Barnett, M.; Goodman, G.; Thorpe, J. D.; Bergan, L.; Thornquist, M. D.; Scholler, N.; Kim, N.; OBriant, K.; Drescher, C.; Urban, N. Assessing lead time of selected ovarian cancer biomarkers: a nested case-control study J. Natl. Cancer Inst. 2010, 102, 26-38
30. Merida, I.; Avila-Flores, A. Tumor metabolism: new opportunities for cancer treatment Clin. Transl. Oncol. 2006, 8, 711-716